Pain catastrophizing, pain acceptance, and pain intensity among patients with cancer in Oman and Lebanon: a comparative cross-sectional study Authors: Jihad Hassan, Maha Dankar, Zeinab Al Azri, Saida Al Maskari, Taif Al Senaidi, Alyamama Al Maqbali, Badour Al Abri Published: 2026 ABSTRACT AbstractBackgroundDespite advances in pharmacological management, cancer-related pain remains highly prevalent. Psychological processes such as pain catastrophizing and pain acceptance may shape pain perception, yet their independent and cross-national contributions remain underexamined.ObjectivesThis study examined psychological, clinical, and contextual predictors of pain intensity among patients with cancer in Oman and Lebanon and explored the statistical mediating role of pain catastrophizing in the association between country and pain intensity.MethodsA comparative cross-sectional study of 200 adult oncology patients (100 per country). Participants completed the Numeric Rating Scale (NRS), the Chronic Pain Acceptance Questionnaire (CPAQ), and the Pain Catastrophizing Scale (PCS). Descriptive statistics, Pearson correlations, multiple linear regression, and mediation analysis using PROCESS were performed.ResultsLebanese participants reported significantly higher pain intensity and catastrophizing scores, whereas Omani participants reported higher pain acceptance. Pain intensity was positively correlated with catastrophizing (r = 0.53, p < 0.001) and negatively correlated with acceptance (r = −0.35, p < 0.001). In multivariable regression, pain catastrophizing (B = 0.05, p = 0.002), country (B = 1.29, p = 0.04), and analgesic use (B = 2.37, p < 0.001) independently predicted pain intensity (adjusted R2 = 0.44). Pain acceptance did not remain independently significant. Exploratory mediation analysis indicated that pain catastrophizing statistically partially mediated the association between country and pain intensity (indirect effect B = 1.23, p < 0.001).ConclusionPain catastrophizing emerged as the most salient psychological predictor of cancer pain intensity and partially explained cross-national differences. Integrating culturally informed cognitive interventions with pharmacological treatment may improve pain outcomes in oncology settings.Keywords: Cancer pain, Supportive care, Psycho-oncology, Oman, Lebanon Introduction Cancer remains a leading cause of morbidity and mortality worldwide and is projected to reach 30.2 million new cases over the next two decades [1, 2]. Pain is among the most prevalent and distressing symptoms in patients with cancer, affecting 33% to 64% across disease stages and up to two-thirds of those with advanced or metastatic disease [3, 4]. Despite advances in cancer treatment and pain management, a substantial proportion of cancer-related pain remains inadequately controlled [5]. Persistent pain negatively affects quality of life, psychological well-being, treatment adherence, and overall functioning [4, 6]. It is a significant symptom affecting up to 50% of patients undergoing active treatment and 90% of those with advanced cancer [7, 8]. Differences in pain experience across countries may reflect not only psychological processes but also variations in healthcare systems, access to analgesics, cultural norms surrounding pain expression, family support structures, and socioeconomic conditions. In Arab societies, sociocultural expectations may influence both the communication of pain and the adoption of coping strategies such as acceptance or catastrophizing [9–11]. Among psychological processes involved in pain perception, pain catastrophizing has attracted substantial attention. It is an exaggerated negative cognitive–emotional response to actual or anticipated pain, characterized by rumination, magnification, and helplessness [12–14]. In oncology settings, pain catastrophizing has been linked to greater emotional distress, heightened pain perception, disability, avoidance behaviors, and poorer quality of life [15, 16]. Patients with high levels of catastrophizing may become overly focused on pain sensations and perceive pain as uncontrollable or overwhelming, which can intensify the subjective pain experience [15, 16]. Within the fear-avoidance model, catastrophic interpretations of pain heighten perceived threat, increase pain-related fear and hypervigilance, and contribute to avoidance behaviors, ultimately reinforcing and intensifying chronic pain experiences [5, 13]. Empirical studies in patients with cancer have shown significant associations between pain catastrophizing and higher pain intensity, greater psychological distress, and poorer functional outcomes [14]. The biopsychosocial model conceptualizes cancer-related pain as a multidimensional experience arising from the interaction of biological factors (e.g., tumor characteristics and treatment-related effects), psychological processes (e.g., pain catastrophizing and pain acceptance), and social and cultural influences, including family support, beliefs about pain, and healthcare context [17, 18]. Within this framework, psychological flexibility serves as an important mechanism by which individuals adapt to persistent pain [17, 18]. In contrast, pain acceptance reflects an adaptive response to persistent pain. Conceptually grounded in psychological flexibility models, it refers to the willingness to experience pain without excessive attempts to control or avoid it, while continuing to engage in meaningful activities and valued life roles [4, 6]. Pain acceptance comprises two components: willingness to experience pain and engagement in activity. Greater acceptance has been associated with improved psychological adjustment and better functioning among individuals living with cancer-related pain [3, 6]. Although pain acceptance and pain catastrophizing represent opposing cognitive–emotional responses to pain, with one amplifying perceived threat and the other promoting adaptive engagement, the biopsychosocial model suggests that these psychological responses interact with biological and social factors to shape the overall pain experience. Nevertheless, their simultaneous contribution to pain intensity in oncology populations remains insufficiently examined [3, 4]. Moreover, the role of sociocultural context in shaping pain perception and cognitive appraisal warrants attention. Cultural beliefs, religious coping practices, family dynamics, healthcare access, and norms regarding emotional expression may influence how patients interpret and respond to pain. Oman and Lebanon differ in demographic structure, cancer epidemiology, and healthcare delivery systems. For example, differences exist in stage at diagnosis, cancer types, and patterns of healthcare utilization [10, 19]. These contextual differences may contribute to variability in reported pain intensity. However, it remains unclear whether country-related differences in pain intensity reflect underlying psychological mechanisms, such as pain catastrophizing, rather than solely clinical or demographic factors. Oman and Lebanon were selected because they represent distinct sociocultural and healthcare contexts within the Arab region, with potential differences in cultural beliefs, healthcare systems, and pain-related experiences that may influence psychological responses to cancer-related pain. Thus, this comparative cross-sectional study aimed to examine the psychological, clinical, and contextual predictors of pain intensity among patients with cancer in Oman and Lebanon and to examine whether pain catastrophizing statistically mediates the association between country and pain intensity. Therefore, the present study aims to: Examine sociodemographic and clinical differences among patients with cancer in Oman and Lebanon Examine sociodemographic and clinical differences among patients with cancer in Oman and Lebanon Investigate the relationships among pain intensity, pain acceptance, and pain catastrophizing Investigate the relationships among pain intensity, pain acceptance, and pain catastrophizing Identify independent psychological, demographic, and clinical predictors of pain intensity using multivariable regression Identify independent psychological, demographic, and clinical predictors of pain intensity using multivariable regression Examine the potential statistical mediating role of pain catastrophizing in the association between country and pain intensity Examine the potential statistical mediating role of pain catastrophizing in the association between country and pain intensity Methods Study design This study used a comparative cross-sectional design to examine pain intensity, acceptance, and catastrophizing among patients with cancer in Oman and Lebanon. Sample, sampling, and sample size The study was conducted at two major governmental tertiary hospitals: Sultan Qaboos University Hospital (SQUH) in Oman and Tripoli Governmental Hospital in Lebanon. A convenience sampling approach was used to recruit eligible patients attending inpatient and outpatient oncology units during the study period. Participants were Omani and Lebanese adults aged 18 years or older, with a clinical cancer diagnosis of any type or stage, admitted to inpatient and outpatient oncology departments at the participating hospitals during the study period, experiencing cancer-related pain, with the cognitive capacity to rate their average pain on a numerical rating scale, cognitively able to provide informed consent and complete the study questionnaires, and able to speak and understand Arabic. Patients with benign tumors, severe cognitive impairment, neurodegenerative diseases, unawareness of their cancer diagnosis, or insufficient capacity to consent or provide required information were excluded from the study. Before recruitment, eligibility regarding cognitive ability and awareness of diagnosis was confirmed by the treating oncologist and using patients’ medical records, with additional input from the psychology team when necessary. The sample size was calculated using G* Power Version 3.1, assuming an effect size (f! = 0.15), an alpha of 0.05, and a power of 0.80 for linear multiple regression: fixed model, R!, deviation from zero, with 10 possible predictors. After the calculation, the study sample size was 100 participants per country. Study instruments Data were collected using a demographic data sheet (DDS) that captured participants’ demographic characteristics (age, sex, marital status, educational level, and employment status) and clinical characteristics (cancer type and stage, time since diagnosis, and other relevant information), as shown in Table 1. Table 1Descriptive statistics of categorical variables between participants from Oman and LebanonVariableOman (n = 100)n (%)Lebanon (n = 100)n (%)p-valueEffect sizeGenderMale62 (62)45 (45)0.02*0.17Female38 (28)55 (55)Marital statusSingle26 (26)16 (16)0.080.12Married74 (74)84 (84)Educational levelIlliterate10 (10)32 (32)0.001*0.27High school or less59 (59)44 (44)University degree31 (31)24 (24)Employment statusEmployee39 (39)18 (18) < 0.001*0.33Not employed14 (14)26 (26)Retired24 (24)12 (12)Housewife23 (23)44 (44)Type of cancerHematologic88 (88)16 (16) < 0.001*0.45Solid12 (12)84 (84)Stage of cancerOne16 (16)11 (11) < 0.001*0.58Two9 (9)38 (38)Third7 (7)30 (30)Fourth9 (9)11 (11)Not specified59 (59)10 (10)MetastasizedYes14 (14)20 (20)0.260.08No86 (86)80 (80)Time since diagnosisless than 2 years69 (69)58 (58)0.240.122 to 5 years18 (18)27 (27)More than 5 years13 (13)15 (15)Treatment for cancerChemotherapy alone86 (86)69 (69)0.001*0.20Combination of treatments14 (14)31 (31)ComorbiditiesYes27 (27)48 (48)0.002*0.22No73 (73)52 (52)Family history of cancerYes22 (22)51 (51) < 0.001*0.30No78 (78)49 (49)Smoking statusNot smoker88 (88)38 (38) < 0.001*0.54Previous smoker11 (11)29 (29)Current smoker1 (1)33 (33)Alcohol statusNot alcoholic99 (99)89 (89)0.003*0.21Previous alcoholic1 (1)11 (11)Physical activityNot active26 (26)26 (26)10Active74 (74)74 (74)Consume analgesicsYes64 (64)61 (61)0.660.03No36 (36)39 (39)n, frequency; %, percentage; *significant p-value < 0.05, **significant at p < 0.001 Descriptive statistics of categorical variables between participants from Oman and Lebanon n, frequency; %, percentage; *significant p-value < 0.05, **significant at p < 0.001 Pain intensity The Numeric Rating Scale (NRS), developed by Farrar in 2001, uses an 11-point scale to assess pain intensity, with 0 indicating no pain and 10 indicating the worst pain. Severity levels are mild [1–3], moderate [4–6], and severe [7–10]. In the current study, the NRS was used to measure average pain intensity over the past 24 h. The NRS demonstrates reliability, with an intraclass correlation coefficient (ICC) of 0.67 and a minimum detectable change (MDC) of 2.6. The Arabic version will be used in this study and has demonstrated high repeatability (ICC = 0.89) and validity (standard error of measurement and MDC = 0.71 and 1.96) [20]. Pain acceptance The Chronic Pain Acceptance Questionnaire (CPAQ), developed by Geisser in 1992, assesses pain acceptance and reduces futile attempts to numb or avoid pain. It has two subscales, activity engagement (AE) and pain willingness (PW), and consists of twenty items. Participants rate each item on a scale from 0 (never true) to 6 (always true). The maximum possible score is 120; higher scores indicate greater pain tolerance. PW items (items 4, 7, 11, 13, 14, 16, 17, 18, and 20) were reverse-scored. The CPAQ scale had Cronbach’s alphas of 0.85 for activity engagement and 0.78 for pain willingness; in the current study, these were 0.92 and 0.83, respectively. This study will use the Arabic version, which has strong reliability (ICC = 0.917) and high internal consistency ((Cronbach’s α = 0.902) [21]. Pain catastrophizing The Pain Catastrophizing Scale (PCS), developed in 1995 by Sullivan and associates, assesses three components: helplessness (e.g., “There is nothing I can do to reduce the intensity of my pain”), magnification (e.g., “I’m afraid that something serious might happen”), and rumination (e.g., “I can’t stop thinking about how much it hurts”). The 13 items of the PCS are scored from 0 to 4, with 0 denoting “not at all” and 4 denoting “all the time”; higher scores indicate greater pain catastrophizing. The Cronbach’s alpha for the original version of the PCS was 0.92; in the current study, it was 0.90. The PCS demonstrates strong internal consistency. This study will use the Arabic version, which shows strong reliability, with a Cronbach’s α of 0.94 and an intraclass correlation coefficient of 0.83 [22]. Data collection procedure Data were collected after obtaining ethical clearance. Written informed consent was obtained from all participants before data collection. Participants attending the oncology departments of the participating hospitals who met the inclusion criteria were approached by the researcher, who provided a full verbal explanation of the study’s aim and procedures. Participants who agreed to participate completed the Arabic-language questionnaire package, which included the demographic questionnaire, the Neumic Rating Scale (NRS), the Pain Catastrophizing Scale (PCS), and the Chronic Pain Acceptance Questionnaire (CPAQ), all available in validated Arabic versions. Participants who were able to read and write completed the questionnaires independently, whereas the researcher administered the questionnaires through face-to-face interviews for participants with low literacy levels or physical limitations that prevented self-completion. During self-administration, the researcher remained available to answer questions and clarify questionnaire items without influencing participants’ responses. Data collection was conducted at the bedside or in a visitors’ room, depending on the participant’s preference and physical condition, to ensure privacy and minimize interruptions to clinical care, doctors’ rounds, sleep, and visiting hours. Data were collected from October 2025 to January 2026, and the entire questionnaire package required approximately 10–15 min to complete. Ethical considerations Ethical approval was obtained from the Research and Ethics Committee of the College of Nursing at Sultan Qaboos University, Oman (CON/GP/2024/22), and from the Research Ethics Committee of Tripoli Governmental Hospital, Lebanon (TGH, 10/15/2025). Administrative permission was also obtained from the participating hospitals before data collection commenced. The study was conducted in accordance with the ethical principles of the Declaration of Helsinki and adhered to internationally accepted standards for research involving human participants. Eligible participants received verbal and written information about the study and provided written informed consent before participation. Participation was entirely voluntary, and participants were informed that they could withdraw from the study at any time without penalty or any effect on the care they received. No financial incentives or other forms of compensation were provided for participation. To protect participants’ privacy, questionnaires were identified using unique study codes rather than personal identifiers, and all information was treated confidentially. Data were stored in password-protected computer files accessible only to the research team and will be retained and securely managed in accordance with institutional policies. Participation involved only completing study questionnaires and was not expected to expose participants to physical or psychological harm. Eligibility was assessed before enrolment to ensure that only individuals meeting the predefined inclusion criteria participated. Statistical analysis Data entry, cleaning, and analysis were conducted in the Statistical Package for the Social Sciences (SPSS), Version 25. Descriptive statistics, including frequencies, percentages, means, and standard deviations, summarized participants’ sociodemographic, clinical, and study variables. Between-group comparisons (Oman vs. Lebanon) were conducted using independent-sample t-tests for continuous variables and chi-square tests for categorical variables, as appropriate. Categorical variables were coded for analysis, with reference categories defined a priori based on theoretical relevance (e.g., Oman = 1, Lebanon = 2; male = 1, female = 2). All multivariable models were constructed using theory-driven covariate selection informed by prior literature, rather than relying solely on bivariate significance testing. Bivariate relationships among study variables were examined using Pearson’s correlation coefficients. Before regression analyses, the assumptions of normality, linearity, homoscedasticity, and multicollinearity were assessed. Multicollinearity was evaluated using the variance inflation factor (VIF) and tolerance statistics. Multiple linear regression analyses were conducted to identify predictors of pain intensity. Missing data were assessed; none was identified, so all cases were included in the final analyses (complete-case analysis). An exploratory cross-sectional mediation analysis was conducted using the PROCESS macro for SPSS (Model 4; Hayes, 2018, version 4.2) to examine whether pain catastrophizing statistically accounted for the association between country and pain intensity. Indirect effects were estimated using 5000 bootstrap samples with bias-corrected 95% confidence intervals. Statistical significance was set at p < 0.05 for all analyses. Results Descriptive statistics A total of 150 patients were screened for eligibility. Of these, 180 met the inclusion criteria in each country. Of the 162 approached, 100 consented to participate, 50 declined, and 12 were excluded due to incomplete data or cognitive impairment. Ultimately, 100 participants from each country were included in the analysis. Table 1 summarizes the sociodemographic and clinical characteristics of participants from Oman and Lebanon. The proportion of male participants was higher in Oman (62%) than in Lebanon (45%). In both countries, the majority of participants were married and had a high school education or less. Employment status differed between the two settings: 39% of participants in Oman were employed, whereas in Lebanon, the largest proportion were housewives (44%). Regarding clinical characteristics, most participants in Oman were diagnosed with hematological malignancies (88%), with more than half (59%) reported at an unspecified stage. In contrast, the majority of participants in Lebanon had solid tumors (84%), with comparable proportions at stages II (38%) and III (30%). In both countries, non-metastatic cancer was more prevalent, accounting for 86% of cases in Oman and 80% in Lebanon. Additionally, a higher proportion of participants had been diagnosed within the past 2 years (69% in Oman and 58% in Lebanon). Chemotherapy as a single treatment modality was reported by most participants, particularly in Oman (86%) and, to a lesser extent, in Lebanon (69%). In Oman, 73% of participants reported no comorbidities, and 78% had no family history of cancer. In Lebanon, 52% reported no comorbidities, while 51% reported a positive family history of cancer. Lifestyle characteristics also differed between countries. In Oman, the majority of participants were non-smokers (88%), whereas in Lebanon, only 38% were non-smokers. Overall, higher proportions of participants in both countries reported being non-alcoholic, physically active, and analgesic users. As shown in Table 1, significant between-country differences were observed in several categorical variables. Gender showed a small but significant difference (p = 0.02, effect size = 0.17), while educational level showed a small-to-moderate effect (p = 0.001, effect size = 0.27). Employment status and type of cancer showed moderate between-country differences (both p < 0.001, effect sizes = 0.33 and 0.45, respectively). A relatively large effect was observed for stage of cancer (p < 0.001, effect size = 0.58). Additional significant differences were found in treatment type (p = 0.001, effect size = 0.20), comorbidities (p = 0.002, effect size = 0.22), family history (p < 0.001, effect size = 0.30), smoking status (p < 0.001, effect size = 0.54), and alcohol status (p = 0.003, effect size = 0.21). No statistically significant differences were observed in physical activity, analgesic use, metastasis status, time since diagnosis, or marital status. Table 2 compares continuous variables between participants from Lebanon and Oman. The mean age of participants in Oman was lower than that of participants in Lebanon (43.58 ± 14.43 vs 58.20 ± 13.61 years, respectively). Pain acceptance scores were higher in Oman (61.79 ± 12.15) than in Lebanon (47.43 ± 18.66). Conversely, pain catastrophizing scores were higher in Lebanon (28.30 ± 15.56) than in Oman (14.55 ± 10.26). Similarly, mean pain intensity scores were higher among Lebanese participants (5.77 ± 3.14) than among those from Oman (2.69 ± 2.81). As shown in Table 2, statistically significant differences were observed between Oman and Lebanon across all continuous variables (p < 0.001). Table 2Comparison of age, CPAQ, PCS, and pain intensity between participants from Oman and LebanonVariableOman (n = 100)Mean ± SDLebanon (n = 100)Mean ± SDp-valueEffect sizeAge43.58 ± 14.4358.20 ± 13.61 < 0.001**1.04Pain acceptance61.79 ± 12.1547.43 ± 18.66 < 0.001**0.91Pain catastrophizing14.55 ± 10.2628.30 ± 15.56 < 0.001**1Pain intensity2.69 ± 2.815.77 ± 3.14 < 0.001**1.03SD, "standard deviation, *significant at p < 0.001 Comparison of age, CPAQ, PCS, and pain intensity between participants from Oman and Lebanon SD, "standard deviation, *significant at p < 0.001 Bivariate analysis As shown in Table 3, bivariate correlations among the study variables were assessed using Pearson’s correlation coefficient. A moderate, negative, and statistically significant correlation was observed between pain intensity and pain acceptance (r = −0.35, p < 0.001), indicating that greater pain acceptance is associated with lower pain intensity. In contrast, a strong, positive, and statistically significant correlation was observed between pain intensity and pain catastrophizing (r = 0.53, p < 0.001), suggesting that greater pain catastrophizing is associated with higher pain intensity. Furthermore, a substantial negative, statistically significant correlation was observed between pain acceptance and pain catastrophizing total scores (r = −0.59, p < 0.001), indicating that higher pain acceptance is associated with lower pain catastrophizing. Table 3Bivariate analysis of continuous variables (n = 200)Variables1234Age-0.15*−0.120.12Pain0.15*-−0.35**0.53**Pain acceptance−0.12−0.35**-−0.59**Pain catastrophizing0.120.53**−0.59**-*Significant p-value < 0.05, **significant at p < 0.001 Bivariate analysis of continuous variables (n = 200) *Significant p-value < 0.05, **significant at p < 0.001 Multivariate analysis Before conducting the multivariate regression analysis, bivariate analyses were performed to assess associations between potential independent variables and the outcome variable, pain intensity. Only variables that were both conceptually related to pain intensity and statistically significant in the bivariate analyses were included in the multivariate linear regression model. The variables entered into the final model were sex, cancer stage, smoking status, pain acceptance, pain catastrophizing, country, cancer type, physical activity, and analgesic use. A p-value < 0.05 was considered statistically significant in both the bivariate and multivariate analyses. A multiple linear regression on the Oman sample found that analgesic consumption was the only significant predictor of pain intensity. Patients with more severe pain were more likely to receive analgesic medications (B = 1.69, 95% CI [0.47, 2.91], p = 0.001). In the Lebanon sample, analgesic use was significantly associated with higher pain intensity (B = 1.69, 95% CI [−4.25, −1.93], p = 0.001). Additionally, pain catastrophizing was a significant positive predictor of pain intensity (B = 1.69, 95% CI [0.02, 0.10], p = 0.01). Subsequently, a multiple linear regression was conducted to identify independent predictors of pain intensity in both countries. The multivariable model was statistically significant (F(10, 189) = 12.12, p < 0.001) and explained 44% of the variance in pain intensity scores (adjusted R2 = 0.44). As shown in Table 4, three variables emerged as significant predictors of pain intensity. Pain catastrophizing was a significant positive predictor of pain intensity (B = 0.05, 95% CI [0.02, 0.08], p = 0.002), indicating that higher levels of pain catastrophizing were associated with greater pain intensity. Country was also a significant predictor (B = 1.29, 95% CI [0.07, 2.52], p = 0.04), with participants from Lebanon reporting higher pain intensity than those from Oman. In addition, analgesic consumption was a significant predictor of pain intensity (B = 2.37, 95% CI [1.59, 3.14], p < 0.001), indicating that higher analgesic use was associated with greater pain intensity. Table 4Multiple linear regression model predicting pain intensity (n = 200)PredictorBβSEtp95% CIAge−0.00−0.010.01−0.210.83−0.03, 0.02Sex (female)0.590.090.391.520.13−0.18, 1.36Cancer stage: not specified−0.16−0.020.61−0.270.79−1.36, 1.04Cancer stage: stage II0.940.120.641.460.15−0.33, 2.21Cancer stage: stage III0.940.110.681.390.17−0.39, 2.28Cancer stage: stage IV0.670.060.780.860.39−0.87, 2.21Smoking (previous)0.710.080.511.390.17−0.29, 1.71Smoking (current)0.800.090.601.350.18−0.37, 1.98Pain acceptance−0.01−0.030.01−0.390.70−0.03, 0.02Pain catastrophizing0.050.230.023.070.002*0.02, 0.08Country (Lebanon)1.290.190.622.080.04*0.07, 2.52Cancer type (hematological)−0.11−0.020.45−0.240.81−1.00, 0.79Physical activity (not active)0.780.100.461.710.09−0.12, 1.68Analgesic use (yes)2.370.340.396.02 < 0.001*1.59, 3.14B unstandardized coefficient, β standardized coefficient, CI confidence interval, p < 0.05 indicates statistical significance.*Significant p-value < 0.05 Multiple linear regression model predicting pain intensity (n = 200) B unstandardized coefficient, β standardized coefficient, CI confidence interval, p < 0.05 indicates statistical significance.*Significant p-value < 0.05 Mediation analysis Table 5 presents the results of the exploratory mediation analysis examining the statistical association between country (X) and pain intensity (Y), with pain catastrophizing as a potential mediator. Country showed a significant total association with pain intensity (B = 3.08, p < 0.001). After including pain catastrophizing in the model, the direct association between country and pain intensity remained statistically significant (B = 1.85, p < 0.001), indicating that the observed association between country and pain intensity was only partially accounted for by differences in pain catastrophizing. Table 5Mediation analysis of the effect of country on pain intensity via pain catastrophizingEffectBSEtpInterpretationTotal effect (c): country → pain intensity3.080.427.30 < 0.001Significant overall association between country and pain intensityDirect effect (c′): country → pain intensity (adjusted for PCS)1.850.444.21 < 0.001Significant direct effect remains after accounting for PCS (partial mediation)Indirect effect (a × b): country → PCS → Pain Intensity1.230.264.66 < 0.001Significant indirect effect, indicating mediation through pain catastrophizing Mediation analysis of the effect of country on pain intensity via pain catastrophizing A statistically significant indirect association of country with pain intensity through pain catastrophizing was observed (B = 1.23, p < 0.001), suggesting that variations in pain catastrophizing were statistically associated with between-country differences in pain intensity. However, this indirect association represents a statistical decomposition of observed group differences and should not be interpreted as evidence of a causal mediation mechanism. Overall, the model explained 34% of the variance in pain intensity (R2 = 0.34). Discussion The present study investigated psychological, clinical, and contextual predictors of pain intensity among patients with cancer in Oman and Lebanon using a pooled multivariable sample. The findings indicate that overall pain intensity was relatively low, which may reflect effective pain management given substantial analgesic use. Further, pain catastrophizing independently predicted pain intensity after adjustment for other variables. However, pain acceptance did not retain independent predictive value in the adjusted model, despite being inversely associated with pain intensity at the bivariate level. Finally, cross-national differences in pain intensity were partially mediated by pain catastrophizing, suggesting that cognitive appraisal processes contribute to contextual disparities in pain experience. Pain catastrophizing emerged as a predictor of pain intensity. This finding aligns with the fear-avoidance model, which posits that catastrophic interpretations amplify perceived threat, increase attentional bias toward pain, and reinforce pain-related fear and hypervigilance, thereby intensifying the subjective pain experience [5, 13]. Empirical evidence in oncology populations supports this mechanism. Wu et al. (14) found that higher levels of catastrophizing were associated with greater postoperative pain severity among patients with lung cancer [14]. Similarly, studies among breast cancer survivors have linked catastrophizing to persistent pain and functional impairment [13]. The present findings extend this literature by showing that catastrophizing predicts pain intensity independently of disease stage and treatment-related variables in a cross-national Arab sample. However, cancer pain should also be understood within a broader biopsychosocial and existential framework rather than solely through cognitive amplification processes such as catastrophizing. Previous studies have demonstrated that psychological distress, depressive symptoms, spiritual well-being, optimism, uncertainty, and psychological flexibility may all contribute to the experience and interpretation of cancer-related pain [6, 23–26]. However, cancer pain should also be understood within a broader biopsychosocial and existential framework rather than solely through cognitive amplification processes such as catastrophizing. Importantly, the mediation analysis showed that pain catastrophizing statistically accounted for part of the observed cross-country differences in pain intensity. Although a statistically significant indirect association was observed between country and pain intensity through pain catastrophizing, this finding should be interpreted as a statistical decomposition of between-country differences rather than evidence of a causal mediation pathway. In this study, country may represent a broad range of contextual factors, including differences in healthcare systems, clinical practices, and treatment availability, which were not directly measured. Therefore, catastrophizing should be viewed as one contributing factor within a broader framework rather than the primary mechanism explaining cross-national differences in pain intensity [27]. In the bivariate analysis, pain acceptance was negatively correlated with pain intensity, consistent with evidence that higher acceptance is associated with improved functioning and reduced symptom interference in chronic pain populations [28]. Studies among cancer patients have similarly shown that acceptance is associated with greater psychological flexibility and quality of life [3, 4]. However, pain acceptance did not independently predict pain intensity in the multivariable model. One plausible explanation is conceptual overlap with catastrophizing, as reflected in the strong negative correlation between acceptance and catastrophizing observed in this study. Varallo et al. (15) similarly reported that higher acceptance was significantly associated with lower catastrophizing and better physical functioning, suggesting that acceptance may attenuate maladaptive cognitive amplification processes [15]. Further, acceptance may influence broader domains such as psychological adjustment, functional engagement [29], and quality of life [30] rather than directly modifying sensory pain intensity. In contrast, catastrophizing appears to function as a more proximal cognitive amplifier of pain perception. This distinction is clinically meaningful, as it suggests that interventions targeting catastrophic thinking may yield more direct reductions in perceived pain intensity, whereas acceptance-based approaches may enhance adaptation and functioning. Analgesic use was strongly associated with higher pain intensity in the multivariable model. While this likely reflects reverse causation, whereby individuals with greater pain are more likely to receive medication, it also highlights the complexity of cancer pain management. Despite pharmacological treatment, patients continued to report clinically high pain intensity [31]. Significant differences in pain intensity were observed between Oman and Lebanon, with Lebanese participants reporting higher pain levels. Country remained a significant predictor after adjustment, suggesting that contextual factors contribute beyond individual characteristics. Higher pain intensity in one sample may reflect differences in disease burden, treatment exposure, healthcare access, or sociocultural approaches to pain reporting, rather than country effects alone [27]. In addition, differences in cancer type distribution, smoking prevalence, comorbidity patterns, healthcare infrastructure, and norms regarding emotional and pain expression may influence reporting behaviors and coping strategies. Research in Oman has identified barriers to optimal pain management, including fear of addiction, concerns about tolerance, and reluctance to report pain due to stigma [32]. These findings highlight the importance of interpreting numeric pain scores within a sociocultural context rather than as purely biomedical indicators. The partial mediation effect suggests that cultural or systemic influences may shape cognitive responses to pain, which in turn influence perceived intensity. Rather than representing the sole mechanism underlying cancer pain, pain catastrophizing should be viewed as one component of a broader biopsychosocial framework in which biological disease processes, treatment-related factors, psychological responses, social support, healthcare access, and existential concerns interact to shape the pain experience. This interpretation is consistent with contemporary biopsychosocial models of cancer pain, which emphasize the dynamic interplay between physical pathology, cognitive appraisal, emotional regulation, and sociocultural context. Clinical implications The findings have important implications for oncology nursing and multidisciplinary cancer care. Pain assessment should extend beyond intensity ratings to include evaluation of pain-related cognitions, particularly catastrophizing, which independently predicts pain severity. Although pharmacological treatment remains central, combined analgesic strategies provide adequate relief in only about 70% of patients [33]. These strategies are associated with adverse effects, including sedation, cognitive impairment, tolerance, and potential dependence. These limitations underscore the need to integrate non-pharmacological interventions targeting modifiable psychological risk factors. Given catastrophizing’s role in amplifying pain perception, cognitive-behavioral therapy (CBT) may offer meaningful adjunctive benefit. Structured psychological interventions have been shown to improve mental health outcomes and quality of life among cancer populations [34]. Acceptance-based approaches may further enhance psychological flexibility and engagement in valued activities [35]. Together, a multidisciplinary model that integrates medical, psychological, and culturally sensitive supportive care may optimize pain outcomes and improve overall quality of life. Overall, psychological interventions targeting catastrophizing may be beneficial when integrated with broader clinical pain management strategies that address treatment access, symptom burden, and the healthcare context. Strengths and limitations This study presents novel cross-national evidence from two Arab countries and employs a pooled multivariable analytic framework to identify independent predictors of pain intensity. Mediation analysis offers insight into potential psychological mechanisms underlying contextual differences. However, several limitations warrant consideration. The cross-sectional design precludes causal inference. Self-reported measures may be influenced by reporting bias and cultural norms. Additionally, unmeasured variables, such as depressive symptoms, anxiety, healthcare access, and socioeconomic status, may contribute to pain outcomes. Longitudinal and interventional studies are needed to clarify temporal relationships and determine whether modifying catastrophizing reduces pain intensity. Conclusion In this cross-national sample of patients with cancer, pain catastrophizing emerged as the most salient psychological predictor of pain intensity, whereas pain acceptance showed correlational but not independent predictive value. Cross-country differences in pain intensity were partially explained by differences in catastrophizing, underscoring the role of cognitive appraisal in shaping cancer-related pain. These findings support integrating culturally informed, psychologically targeted, non-pharmacological interventions alongside pharmacological treatment in oncology settings. Addressing maladaptive cognitive amplification processes may enhance pain control, reduce excessive reliance on medication, and advance comprehensive cancer care. Acknowledgements The authors wish to thank the nurses who voluntarily participated in this study. Author contribution Jihad Hassan: Conceptualization, Methodology, Project administration, Formal Analysis, Original draft preparation, Writing- Reviewing and Editing. Dr. Maha Dankar: Methodology, Investigation, Original draft preparation, Writing- Reviewing and Editing. Zeinab Alazri: Conceptualization, Methodology, Original draft preparation, Writing- Reviewing and editing. Saida Al maskari: Conceptualization, Methodology, Analysis, Writing- Reviewing and Editing. Taif Al senaidi: Conceptualization, Methodology, Writing- Reviewing and Editing. Alyamama Almaqbali: Conceptualization, Methodology, and Writing- Reviewing and Editing. Badour Alabri: Conceptualization, Methodology, and Writing- Reviewing and Editing. Funding Open access funding provided by Sultan Qaboos University. Data availability The data are available from the corresponding author and can be shared upon reasonable request. Declarations Ethical approval Ethical clearance was obtained from the Research and Ethics Committee of the College of Nursing at Sultan Qaboos University in Oman and Tripoli Governmental Hospital in Lebanon. Consent to participate Written informed consent was obtained from all participants before data collection. Competing interests The authors declare no competing interests Declaration of generative AI and AI-assisted technologies in the manuscript preparation process During the preparation of this manuscript, the authors used ChatGPT solely for language editing and readability improvements. The authors reviewed and revised all text and take full responsibility for the manuscript’s accuracy, integrity, and originality. Clinical trial number Not applicable. Footnotes Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The data are available from the corresponding author and can be shared upon reasonable request.